2013 weight reza wp v3
TRANSCRIPT
-
8/12/2019 2013 Weight Reza WP v3
1/14
2012 - 2013 SABINSA CORPORATION 1
I N N O V A T I V E
I N G R E D I E N T SN S U P P O R T O F
W E I G H T
M A N A G E M E N T
AUTHORS:
MUHAMMED MAJ EED, PH. D. R EZ A K AMAR EI , PH.D.
2 0 L a k e D r i v e , E a s t W i n d s o r, N J 0 8 5 2 0
l : 732 . 777 . 1111 E m a i l : i n f o @ s a b i n s a . c o m We b : w w w . s a b i n s a . c o m
mailto:[email protected]:[email protected]:[email protected]://www.sabinsa.com/http://www.sabinsa.com/http://www.sabinsa.com/mailto:[email protected]:[email protected] -
8/12/2019 2013 Weight Reza WP v3
2/14
!"#$% '(") *+,-./01%23 )$#$/+4 "%%0#+5#$ %+'1/+4 "%./$2"$%') '(+'
)1660/' 7$".(' 8+%+.$8$%' (+#$ *$$% 2"),0#$/$2 +%2 2$#$406$2 *9
:+*"%)+;
-
8/12/2019 2013 Weight Reza WP v3
3/14
!"#$% '( )*+"*,- .,/ !.")*+"*,-
!"#$% )( 01.,!."/-
23#45*,.6#, #7 !.")*+"*,- .,/ 8#"901.,-: %;$9 E($ *"0+,5#$ "%./$2"$%') 0@ '(") @/1"' +/$ F92/0A9,"'/", +,"2 +%2
!+/,"%04 CG".> H + I *D>
2012 - 2013 SABINSA CORPORATION 3
8*H I.( JK/"#LK3*+"*3 .3*/ 8*H I5( !."3*,#;
-
8/12/2019 2013 Weight Reza WP v3
4/14
I> )*+"*,-
*$@0/$ 8$+4)D
G".> \ )(07) '($ $]$,' 0@ 2+"49 +28"%")'/+50% 0@ J) "' ,+% *$ )$$%3 '($/$
") + 802$)' 2$,/$+)$ "% *029 7$".(' +^$/ Y 7$$-) = $_1+449 "% @$8+4$) +%2 8+4$)> E($ 80)' 0*#"01) _1$)50%
") +*01' '($ 8$,(+%")8 0@ +,50% *$("%2 '($ 7$".(' 40))> E($/$ +/$ '70 8$,(+%")8) "%#04#$2 ($/$W B%("*"50%
0@ @+S9 +,"2 )9%'($)") +%2 )5814+50% 0@ @+S9 +,"2 0A"2+50% C` 0A"2+50%D>
J) @+/ +) "%("*"50% 0@ @+S9 +,"2 )9%'($)") ") ,0%,$/%$23 F92/0A9,"'/", J,"2 (+) HNN 58$) ./$+'$/ +a%"'9 @0/ '($
$%L98$ ,"'/+'$ 49+)$3 +%23 '($/$@0/$3 "' +,') +) + 60'$%' "%("*"'0/ 0@ ,"'/+'$ 49+)$> X1$ '0 '($ "%("*"50% 0@
,"'/+'$ 49+)$3 #$/9 4"S4$ J,$'94
-
8/12/2019 2013 Weight Reza WP v3
5/14
)9%'($)")> J) @+/ +) 6/08050% 0@ @+' 40)) #"+ )5814+50% 0@ @+S9 +,"2 0A"2+50% C0/ ` 0A"2+50%D ") ,0%,$/%$2
@+S9 +,"2) +/$ '/+%)60/'$2 "%'0 8"'0,(0%2/"+ *9 4"%-"%. 7"'( c=,+/%"5%$> E(") 4"%-+.$ ") @+,"4"'+'$2 *9 c=
,+/%"5%$ '/+%)@$/+)$> J) )'+'$2 +*0#$3 "% '($ 6/$)$%,$ 0@ F E(") /$64$%")($) '($ )'0/$2 .49,0.$% )'0/+.$ "% 4"#$/> E($ (".(
4$#$4 0@ .49,0.$%3 +) + /$)14' 0@ (".( .41,0)$ )166493 ") '/+%)4+'$2 *9 '($
E($ 7+'$/=)041*4$ 60'+))"18 )+4' 0@ . */ -8. .?.$- %,
,(";;>k E(") ,0%,41)"0% ") ,086+5*4$ 7"'( '($ )8+44 0/ 802$)' 7$".(' 40)) )(07% "% G". \> E($ /$+)0% @0/ '(")0*)$/#+50% ,0142 60))"*49 *$ '(+' F
2012 - 2013 SABINSA CORPORATION 5
Female Male All
1.6
1.4
1.2
1
0.8
0.6
0.4
0.2
0
Effect of daily administration of on relative appetite -
self assessment
Citrin
Before CitrinAfter 4 wksAfter 8 wks)
BodyWeight(lbs)
-
8/12/2019 2013 Weight Reza WP v3
6/14
M> !.")*+"*,-
!+/
-
8/12/2019 2013 Weight Reza WP v3
7/14
!"#$% 5*;.7, /*#,@*8;%% (+) *$$%
)'12"$2 $A'$%)"#$49> E($ 80)' /$,$%' /$#"$7 ") + *00- ,(+6'$/ 5'4$2 j5*;.7, /*#,@*8;%% oA'/+,' "% '($
U+%+.$8$%' 0@ i*$)"'9k 7/"S$% *9 X/> U+V$$23 '($ G01%2$/ +%2
e$)14') 0@ 0%$ 0@ '($ $+/4"$)' ,4"%",+4 '/"+4) 0% G0/)c$+%; C?+28+$#3 U+V$$23 .- ";
\NN\D ") )(07% "% G". T> B% '(") Y=7$$-3 6"40' 06$% Z$42 )'1293 T 0#$/7$".(' 708$%
/$,$"#$2 MNN 8. G0/)c$+% C0/ MN 8. G0/)-04"%D 6$/ 2+9> J) "' ,+% *$ )$$%3 +^$/ Y
7$$-)3 '($/$ 7+) + ,0%)"2$/+*4$ 7$".(' 40)) I @+' 40))3 +%2 "%,/$+)$ "% 4$+% *029
8+))>
2012 - 2013 SABINSA CORPORATION 7
8*H N(
8*H O( D*HP+ Q11R G+$/K
-
8/12/2019 2013 Weight Reza WP v3
8/14
G".> g )(07) +%0'($/ ,4"%",+4 '/"+4 0% G0/)c$+%; C?(+.7+' .- ";3 \NN[D> B% '(") H\=7$$-3 201*4$=*4"%2 +%2
/+%208"L$2 )'1293 TN 0*$)$ )1*V$,') /$,$"#$2 MNN 8. G0/)c$+%; CMN 8. G0/)-04"%D 6$/ 2+9> J) "' ,+% *$ )$$%
+^$/ H\ 7$$-)3 '($/$ 7+) H>gQ -. 0@ 7$".(' 40)) "% '($ '$)' ./016b ,086+/$2 '0 N>\M -. 0@ 7$".(' .+"% "% '($
64+,$*0 ./016>
2012 - 2013 SABINSA CORPORATION 8
G".> Y )(07) 9$' +%0'($/ ,4"%",+4 '/"+4 0%
G0/)c$+%; CR+8+'(3 \NN[D> B% '(") H\=
7$$-3 /+%208"L$2 )'1293 MN 8+4$ +%2
@$8+4$ )1*V$,') /$,$"#$2 \MN 8. 0@
G0/)c$+%; 0/ p4+,$*0 ,+6)14$) = '7",$ +
2+9> J) )(07%3 +^$/ H\ 7$$-)3 '($/$ ")
\>gO 7$".(' 40)) +%2 H>YO @+' 40)) "%
'($ '$)' ./016b ,086+/$2 '0 N>PO +%2
N>\O @0/ '($ 64+,$*0 ./016> J4)03 '($/$
") H>YO "%,/$+)$ "% 4$+% *029 8+)) "%
'($ '$)' ./016 ,086+/$2 '0 N>\O2$,/$+)$ "% '($ 4$+% *029 8+)) "% '($
64+,$*0 ./016>
8*H S( 8#"901.,;DT13+ #, Q1*HP+:
-
8/12/2019 2013 Weight Reza WP v3
9/14
:6$,"Z,+4493 G0/)-04"% +,5#+'$) '($
$%L98$ +2$%94+'$ ,9,4+)$3 '($ 8+"% $%L98$ "%#04#$2 "% '($ 6/021,50%
0@ ,9,4", +2$%0)"%$ 80%06(0)6(+'$3 0/ ,JUp3 /$@$//$2 '0 "% '($
4"'$/+'1/$ +) '($ s)$,0%2 8$))$%.$/>j
G04407"%. '($ *"0,($8",+4 6+'(7+9 )(07% 0% '($ /".(' 0@ G". P3 ,9,4",
JUp @+,"4"'+'$) '($ +,50% 0@ s6/"8+/9 8$))$%.$/)s 0/ #+/"01) (0/80%+4
+%2 *"0+,5#$ )1*)'+%,$) "% '($ *029 C)1,( +) "%)14"% +%2 '(9/0'/06"%D>
2012 - 2013 SABINSA CORPORATION 9
8*H [( U13P.,*94 #7 .36#, #7 8#"901.,-
-
8/12/2019 2013 Weight Reza WP v3
10/14
?9 @+,"4"'+5%. (0/80%+4 +,50%3 ,9,4", JUp 8+9 ,0%'/"*1'$ '0 '($ "%,/$+)$
"% '($ 8$'+*04", /+'$ +%2 '($/80.$%$)")> E($)$ $#$%') ,0//$)60%2 '0 '($
*1"4216 0@ 4$+% *029 8+))>
G04407"%. *"0,($8",+4 6+'( )(07% 0% '($ 4$^ 0@ G". P3 +% "%,/$+)$ "%
,9,4", JUp 4$+2) '0 '($ )1*)$_1$%' +,5#+50% 0@ 6/0'$"% -"%+)$> p/0'$"%
-"%+)$ (+) *$$% )(07% '0 +,5#+'$ '($ (0/80%$ )$%)"5#$ 4"6+)$ 7(",( ")
"%#04#$2 "% '($ */$+-207% 0@ '/".49,$/"2$) = -%07% +) *1"42"%. *40,-) 0@
@+S9 5))1$> E($)$ $#$%') ,0//$)60%2 '0 '($ 2$,/$+)$ "% *029 @+'>
J) @+/ +) 20,18$%'$2 :+@$'9 ") ,0%,$/%$23 G0/)c$+%; ") 7$44='04$/+'$237"'(01' +2#$/)$ )"2$ $]$,')> G0/)c$+%; +' MNN8.f2+9 CMN 8. @0/)-04"%f
2+9D @0/ 16 '0 H\ 7$$-)3 6/021,$2 %0 )".%"Z,+%' 2$'/"8$%'+4 $]$,') 0%
*"0,($8")'/93 ($8+'040.",+4 6+/+8$'$/)3 *4002 6/$))1/$ 0/ '(9/0"2
@1%,50%) C
-
8/12/2019 2013 Weight Reza WP v3
11/14
!"#$% )( 01.,!."/-
c$+%!+/2; ") + 6/06/"$'+/9 *4$%2 0@ !+/Q '0 N>MO p"6$/"%$D
E($ -$9 60"%' +*01' c$+%!+/2; ") '(+' 7$ +/$ ,08*"%"%. '70 2"]$/$%' ./016) 0@ *"0+,5#$ "%./$2"$%') 7"'(
,0864$8$%'+/9 8$,(+%")8) 0@ +,50% @0/ 7$".(' 8+%+.$8$%'> E($ '("/2 "%./$2"$%'3 ?"0p$/"%$; ") + ,4"%",+449
6/0#$%3 %+'1/+4 *"0+#+"4+*"4"'9=$%(+%,$/ @0/ %1'/"$%')> B' 8+9 +4)0 (+#$ + /04$ "% 6/$#$%5%. 2"]$/$%5+50% 0@
+2"60,9'$)> ?"0p$/"%$; ") + )'+%2+/2"L$2 $A'/+,' 0*'+"%$2 @/08 *4+,- 6$66$/3 ,0%'+"%"%. PM=PPO 6"6$/"%$ +%2
") + )$4@=+a/8$2 !eJ: )1*)'+%,$ 7"'( '($ /$,088$%2$2 1)$ 4$#$4 0@ M8.f20)$>
U+V$$2 .- "; C\NNPD ,0%21,'$2 + ,4"%",+4 '/"+4 '0 "%#$)5.+'$ '($ $a,+,9 +%2 )+@$'9 0@ c$+%!+/2;> E($
6+/+8$'$/) 0@ '($ )'129 7$/$ +) @04407)W
X$)".%W 64+,$*0=,0%'/044$23 /+%208"L$23 201*4$ *4"%2 6+/+44$4=./016
:1*V$,')W MN 0#$/=7$".(' )1*V$,') "% $+,( ./016 ,086/")"%. 0@ \[ U$% +%2 \T l08$% /+%."%. "% +.$
@/08 \M '0 MM 9$+/)>
:'129 X1/+50%W H\ 7$$-)
X0)+.$W MNN8. 0@ '($ c$+%!+/2; 0/ p4+,$*03 '7",$ + 2+9
8*H\ IY )(07) '(+'
c$+%!+/2; ,+1)$2
g>MO /$21,50% "%
'($ )*>1 :.%+8- 0@
' ( $ ' $ ) ' . / 0 1 6,086+/$2 '0 H>HO "%
'($ 64+,$*0 ./016>
2012 - 2013 SABINSA CORPORATION 11
-
8/12/2019 2013 Weight Reza WP v3
12/14
8*H\ II)(07) '(+' c$+%!+/2; ,+1)$2 Y>HMO /$21,50% "% '($ )*>1 /"-0@ '($ '$)' ./016 ,086+/$2 '0 H>HYO "%
'($ 64+,$*0 ./016>
8*H\ IM)(07) '(+' c$+%!+/2; ,+1)$2 [>QTO "%,/$+)$ "% '($ ;."& )*>1 (",,0@ '($ '$)' ./016 ,086+/$2 '0
N>TgO "% '($ 64+,$*0 ./016> G1/'($/80/$3 c$+%!+/2; 2"2 %0' ,+1)$ +%9 )".%"Z,+%' ,(+%.$) "% *4002 6/$))1/$
0/ ($+/' /+'$3 ($8+'040.",+4 6+/+8$'$/)3 4"#$/ @1%,50%3 /$%+4 @1%,50%3 '(9/0"2 @1%,50%3 +%2 64+)8+ 4"6"2
4$#$4)> ?+)$2 0% '($ /$)14') 0@ '($ +*0#$ ,4"%",+4 )'1293 "' ") ,0%,412$2 '(+' c$+%!+/2; ") +% $]$,5#$ +%2
,4"%",+449 )+@$ 2"$'+/9 )1664$8$%' "% )1660/' 0@ 7$".(' 8+%+.$8$%'>
2012 - 2013 SABINSA CORPORATION 12
-
8/12/2019 2013 Weight Reza WP v3
13/14
!"#$% ?( 8.51,#;-
G+*$%04; ") +% +46(+=+894+)$ "%("*"'0/9 %+'1/+4 $A'/+,' 0*'+"%$2 @/08 A8",.*;7, B7;+"#%, C,0880% *$+%
-"2%$9 *$+%D '(+' *40,-) '($ 2".$)50% 0@ 2"$'+/9 )'+/,(> J46(+ +894+)$ ,+'+49L$) '($ (92/049)") 0@ u=CH3[D
.49,0)"2", 4"%-+.$) 0@ )'+/,(> E($ +46(+ +894+)$ "%("*"'0/ ") "2$%5Z$2 "% '($ 6/0'$"% @/+,50% 0@ '($ *$+%
G+*$%04; ") %0' 2"/$,'49 "%#04#$2 "% '($ 7$".(' 40)) 6/0,$))> F07$#$/3 "' "%2"/$,'49 )1660/') 7$".(' 40)) +) "'
)1660/') '($ "%("*"50% 0@ )1.+/ @0/8+50% @/08 )'+/,( */$+- 207%> J894+)$ "%("*"'0/) +4)0 +4'$/ '($ +801%'
+%2 6+S$/% 0@ @002 "%'+-$ +%2 /$21,$ 7$".(' .+"% '(/01.( "%21,"%. )+5$'9 +%2 "%,/$+)"%. ,+/*0(92/+'$
2$4"#$/9 '0 '($ "4$18 +%2 ,040%>
oA,$)) )'+/,( "% '($ 2"$' ") ,0%#$/'$2 '0 .41,0)$ "% '($ !B '/+,' +%2 160% +*)0/650% ") ,0%#$/'$2 '0 @+') +%2
)'0/$2 "% '($ *029> J% +46(+=+894+)$ "%("*"'0/ "%("*"') '($ 2".$)50% 0@ )'+/,( '($/$*9 60'$%5+449 "86/0#"%.
60)'6/+%2"+4 ,+/*0(92/+'$ '04$/+%,$ "% 6$064$ 7"'( 407 .41,0)$ '04$/+%,$> J) $A,$)) 2"$'+/9 ,+/*0(92/+'$ ")
8$'+*04"L$2 '0 @+'3 "%("*"50% 0@ ,+/*0(92/+'$ 2".$)50% ($46) "% 7$".(' 8+%+.$8$%'>
J% +894+)$ "%("*"'0/ 0*)'/1,') '($ 2".$)50% 0@ )'+/,( +%2 +*)0/650% 0@ .41,0)$> E($/$@0/$ +894+)$ "%("*"'0/)
+/$ #+41$2 "% ,0%2"50%) )1,( +) 2"+*$'$) C'0 /$21,$ *4002 )1.+/ 4$#$4)D +%2 "% 7$".(' 8+%+.$8$%'> :"%,$ '($
+46(+=+894+)$ "%("*"'0/ 6/0'$"% *"%2) 7"'( '($ +,5#$ )"'$) 0@ +46(+= +894+)$ +%2 6/$#$%') "') )'+/,(
2$./+2+50% +,5#"'93 "' ") +4)0 ,+44$2 j:'+/,( ?40,-$/k>
G*H\ I])(07) )$$2) 0@ A8",.*;7, B7;+"#%,+%2 G+*$%04r) +46(+ +894+)$ "%("*"'0/9 +,50%> G+*$%04; ") 0]$/$2
"% '70 )'/$%.'()W :'+%2+/2 G+*$%04; C$+,( ./+8 6/$#$%') 2".$)50% 0@ H\N ./+8) )'+/,(D +%2 G+*$%04; U+A
C$+,( ./+8 6/$#$%') 2".$)50% 0@ QNN ./+8) )'+/,(D> E($ /$,088$%2$2 20)$ 0@ G+*$%04; ") \>M '0 Q>gM .
*$@0/$ 8$+4) +%2 @0/ G+*$%04; U+A ") H '0 H>M . *$@0/$ 8$+4)>
2012 - 2013 SABINSA CORPORATION 13
1.2
1
0.8
0.6
0.4
0.2
00.8250.550.2750.13750.06825SE
Alpha-amylase
Activity(Units/ml)
Inhibitor Concentration (mg/ml)
*SE - Standard: amylase enzyme (Sigma)
Alpha-Amylase Inhibitory action of Fabenol
-
8/12/2019 2013 Weight Reza WP v3
14/14
F171"1,319
v?+28+$# w3 U+V$$2 U CHPPMD i6$% Z$423 6(9)","+% ,0%'/044$23 ,4"%",+4 $#+41+50% 0@ *0'+%",+4 7$".(' 40))
@0/814+ ?> p+'$4 e$)$+/,(
vU+V$$2 U3 ?+28+$# w3
vU+V$$2 U3 ?+28+$# w3 R(+% d3 p/+-+)( c3 R+49+%+8 d C\NNPD J %$7 ,4+)) 0@ 6(9'0%1'/"$%') @0/ *0297$".(' 8+%+.$8$%'> d1'/+G002)3 Y CHD Hg>
vi%+-609+ B3 F1%. :R3 p$//9 e3 l"2$/ ? +%2 o/%$)' o C\NHHD E($ 1)$ 0@ !+/,"%"+ $A'/+,' CF92/0A9,"'/", J,"2D +)
+ 7$".(' 40)) )1664$8$%'> J )9)'$8+5, /$#"$7 +%2 8$'+=+%+49)") 0@ /+%208"L$2 ,4"%",+4 '/"+4)3 h01/%+4 0@
i*$)"'93 #0418$ \NHH3 J/5,4$ BX MNPNQY3P 6+.$)> X0"WHN>HHMMf\NHHfMNPNQY>
vE(08 o CHPPTD F92/0A9,"'/+'$ CF h> i*$)"'9 \N C[DW gM>
2012 - 2013 SABINSA CORPORATION 14